Trial Information
Inclusion Criteria:
1. Histologic diagnosis of advanced stage or metastatic GIST
2. Asian patient (as defined by the investigator)
3. First line treatment with imatinib
4. Availability of tumor samples for kit mutation analysis
5. Availability of tumor response rate and or time to progression data
Exclusion Criteria:
-
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Retrospective
Authority:
Singapore: Domain Specific Review Boards
Study ID:
GA03/17/10
NCT ID:
NCT01227746
Start Date:
July 2010
Completion Date:
Related Keywords:
- Asian Patients With Advanced Gastro-intestinal Stromal Tumors (GIST) Treated With Imatinib
- Advanced gastro-intestinal stromal tumors
- Gastrointestinal Stromal Tumors